Roles of tumor necrosis factor-related apoptosis-inducing ligand in corneal transplantation

Transplantation

Volumn 76, Issue 11, 2003, Pages 1556-1559

  Xie, Lixin ^a   Shi, Weiyun ^b   Guo, Ping ^b  

^a SHANDONG EYE INSTITUTE   (China)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DEATH RECEPTOR 5; GREEN FLUORESCENT PROTEIN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ADENOVIRUS; ALLOGRAFT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; CORNEA TRANSPLANTATION; GRAFT FAILURE; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOHISTOCHEMISTRY; INFLAMMATION; KERATOPLASTY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SURVIVAL TIME; TUMOR CELL;

ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CORNEAL TRANSPLANTATION; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MODELS, ANIMAL; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0346218094     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000089242.86443.40     Document Type: Article

References (9)

1. Hill JC. Systemic cyclosporine in high-risk keratoplasty. Short-versus long-term therapy. Ophthalmology 1994; 101: 128.
2. Rehany U, Waisman M. suppression of corneal allograft rejection by systemic cyclosporine-A in heavily vascularized rabbit corneas following alkali burns. Cornea 1994; 13: 447.
3. Wiley SR, Schooley K, Smolak PJ, et al. Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 1995; 3: 673.
4. Ashkenazi A, Pai RC, Fong S, et al. Safety and antitumor activity of recombinant soluble Apo2 ligand. J Clin Invest 1999; 104: 155.
5. Stuart PM, Griffith TS, Usui N, et al. CD95 ligand (FasL) induced apoptosis is necessary for corneal allografts survival. J Clin Invest 1997; 99: 396.
6. Chen YF, Gebhardt BM, Reidy JJ, et al. Cyclosporine-containing collagen shields suppress corneal allograft rejection. Am J Ophthalmol 1990; 109: 132.
7. Rayner SA, Larkin DF, George AJ. TNF receptor secretion after ex vivo adenoviral gene transfer to cornea and effect on in vivo graft survival. Invest Ophthalmol Vis Sci 2001; 42: 1568.
8. Song K, Chen Y, Goke R, et al. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is an inhibitor of autoimmune inflammation and cell cycle progression. J Exp Med 2000; 191: 1095.
9. Hilliard B, Wilmen A, Seidel C, et al. Roles of TNF-related apoptosis-inducing ligand in experimental autoimmune encephalomyelitis. J Immunol 2001; 166: 1314.